...delivery technology. Retrophin Inc. (OTCQB:RTRX), New York, N.Y. Transcept Pharmaceuticals Inc. (NASDAQ:TSPT), Point Richmond, Calif. Roumell Asset Management LLC...

...approved products. TO-2070 is now listed as Transcept's lead compound. Earlier this month, Transcept shareholders Roumell Asset Management LLC...

...Intermezzo is a low-dose sublingual formulation of zolpidem, a GABA A receptor modulator. Transcept shareholder Roumell Asset Management LLC...

..."will be able to announce progress in re-building our development pipeline." The company's largest shareholder, Roumell Asset Management LLC...